Direct Oral FXa Inhibitors Binding to Human Serum Albumin: Spectroscopic, Calorimetric, and Computational Studies
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24054900 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nory Mariño-Ocampo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Química, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile. Hauptthemen laut MEDLINE: Serum Albumin, Human, Venous Thromboembolism, Factor X. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANID/CONICYT FONDECYT.
Abstract (Originalsprache)
Direct FXa inhibitors are an important class of bioactive molecules (rivaroxaban, apixaban, edoxaban, and betrixaban) applied for thromboprophylaxis in diverse cardiovascular pathologies. The interaction of active compounds with human serum albumin (HSA), the most abundant protein in blood plasma, is a key research area and provides crucial information about drugs’ pharmacokinetics and pharmacodynamic properties. This research focuses on the study of the interactions between HSA and four commercially available direct oral FXa inhibitors, applying methodologies including steady-state and time-resolved fluorescence, isothermal titration calorimetry (ITC), and molecular dynamics. The HSA complexation of FXa inhibitors was found to occur via static quenching, and the complex formation in the ground states affects the fluorescence of HSA, with a moderate binding constant of 104 M−1. However, the ITC studies reported significantly different binding constants (103 M−1) compared with the results obtained through spectrophotometric methods. The suspected binding mode is supported by molecular dynamics simulations, where the predominant interactions were hydrogen bonds and hydrophobic interactions (mainly π–π stacking interactions between the phenyl ring of FXa inhibitors and the indole moiety of Trp214). Finally, the possible implications of the obtained results regarding pathologies such as hypoalbuminemia are briefly discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Escuela de Química, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.
- Center for Bioinformatics and Integrative Biology, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago 8370035, Chile.
- Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.
- Centro de Investigaciones en Nanotecnología y Materiales Avanzados, CIEN-UC, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.
- Center for Nanomedicine, Diagnostic & Drug Development (ND3), Universidad de Talca, Talca 3460000, Chile.
ORCID-Profile: Nory Mariño-Ocampo, Diego F Rodríguez, Daniel Zúñiga-Núñez, Denis Fuentealba, Flavia C Zacconi
Förderung
- ANID/CONICYT FONDECYT
Zitieren
APA
Mariño-Ocampo, N., Rodríguez, D. F., Guerra Díaz, D., Zúñiga-Núñez, D., Duarte, Y., Fuentealba, D., & Zacconi, F. C. (2023). Direct Oral FXa Inhibitors Binding to Human Serum Albumin: Spectroscopic, Calorimetric, and Computational Studies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054900
Vancouver
Mariño-Ocampo N, Rodríguez DF, Guerra Díaz D, Zúñiga-Núñez D, Duarte Y, Fuentealba D, et al. Direct Oral FXa Inhibitors Binding to Human Serum Albumin: Spectroscopic, Calorimetric, and Computational Studies. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054900
BibTeX
@article{MarioOcampo2023,
author = {Mariño-Ocampo, Nory and Rodríguez, Diego F and Guerra Díaz, Daniel and Zúñiga-Núñez, Daniel and Duarte, Yorley and Fuentealba, Denis and Zacconi, Flavia C},
title = {Direct Oral FXa Inhibitors Binding to Human Serum Albumin: Spectroscopic, Calorimetric, and Computational Studies},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24054900}
}
EUVIMED